Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07126795 · ClinicalTrials.gov registry record · Phase 1

Magnesium Sulfate in Pediatric Burn Dressing Changes

A Phase 1 study, sponsored by Hennepin Healthcare Research Institute.

Not yet
Registry status
Phase 1
Development phase
10
Enrollment target

NCT07126795: Clinical Trial Phase 1 study, sponsored by Hennepin Healthcare Research Institute.

NCT07126795 is a Phase 1 study that has not yet begun recruiting, run by Hennepin Healthcare Research Institute. The registered enrollment target is 10 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07126795, a Phase 1 study, has not yet begun recruiting, sponsored by Hennepin Healthcare Research Institute.

NOT YET RECRUITING
Registry status
Phase 1
Development phase
10 participants
Enrollment target

Study Summary

Prospective feasibility trial utilizing adjuvant magnesium sulfate for analgesia/sedation during pediatric sedated burn dressing changes, which is ultimately hypothesized to decrease ketamine and/or sedative requirements.

Primary Outcome

Frequency of severe adverse events

Interventions

  • DRUG Normal Saline (0.9% NaCl)
  • DRUG magnesium sulfate

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2026-01-01
Est. Completion 2027-01-01
Phase Phase 1

What is known before NCT07126795 opens enrollment

NCT07126795 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (83% lower).

The record links to 0 conditions, and to 2 interventions - of which Normal Saline (0.9% NaCl) is the first listed.

NCT07126795 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT07126795 about?

NCT07126795 is a clinical study titled "Magnesium Sulfate in Pediatric Burn Dressing Changes". Prospective feasibility trial utilizing adjuvant magnesium sulfate for analgesia/sedation during pediatric sedated burn dressing changes, which is ultimately hypothesized to decrease ketamine and/or sedative requirements.

What is the current status of trial NCT07126795?

This trial is currently not yet recruiting. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2026-01-01. Estimated completion is 2027-01-01.

What interventions are being tested in trial NCT07126795?

The interventions under investigation include: Normal Saline (0.9% NaCl) (DRUG), magnesium sulfate (DRUG).

Who is sponsoring clinical trial NCT07126795?

This trial is sponsored by Hennepin Healthcare Research Institute, which has 63 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT07126795's enrollment target sits among peer trials

10 1913th of 2000 higher than 46 of 2,000 other Phase 1 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT07126795, the US trial registry maintained by the National Library of Medicine. NCT07126795 (small enrollment · none site footprint · not yet recruiting) retrieved and formatted by PlainTrial, see methodology.